Prashant Singri

Instructor, Clinical, Dermatology

Emailp-singri@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Dermatology

Training Experience

2005	Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, Northeastern Ohio University

… → 1999

Fingerprint

Dive into the research topics where Prashant Singri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Active
6 Finished

Prot #C0168Z03: A Multicenter, Open Registry of Patients with Psoriasis Who are Candidates for Systemic Therapy Includes Biologics
Amin, A. Z., Laumann, A. E., Singri, P., West, D. P. & Paller, A.
Mapi USA, Inc., Janssen Biotech, Inc.
3/2/09 → 3/2/21
Project: Research project
Prot# CC-10004-PSOR-009: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects with Moderate to Severe Plaque Psoriasis
Laumann, A. E. & Singri, P.
INC Research, LLC, Celgene Corporation
7/14/11 → 7/14/17
Project: Research project
PROT# MEL-041509: Phase II Randomized, Double-Blind, Placebo-Controlled, Three-Arm,Dose-Finding, Study to Evaluate the Safety and Efficacy of Erlotinib in the Treatment of Moderate to Severe Psoriasis
Laumann, A. E., Singri, P. & West, D. P.
OSI Pharmaceuticals, Inc.
10/7/09 → 10/7/12
Project: Research project
Prot# 20040210: Observational Post-Marketing Safety Surveillance Registry of Enbrel® (etanercept) for the Treatment of Psoriasis
Singri, P. & West, D. P.
Omnicare Clinical Research, Immunex Corporation
10/17/06 → 2/5/08
Project: Research project
Prot# CTA018-CL-2001-1: A Randomized, Double-Blind, Parallel-Group, 4-Arm, 12 Week Study to Evaluate the Safety and Efficacy of Topically Applied CTA018 vs. Vehicle for the Treatment of Adult Subjects with Chronic Plaque Psoriasis
Laumann, A. E., Singri, P. & West, D. P.
Cytochroma Inc.
8/17/06 → 1/3/08
Project: Research project

153 Citations
4 Article
1 Review article

Inflammatory acne management with a novel prescription dietary supplement
Shalita, A. R., Falcon, R., Olansky, A., Iannotta, P., Akhavan, A., Day, D., Janiga, A., Singri, P. & Kallal, J. E., Dec 2012, In: Journal of Drugs in Dermatology. 11, 12, p. 1428-1433 6 p.
Research output: Contribution to journal › Article › peer-review
11 Scopus citations
Biologic therapy for psoriasis: The new therapeutic frontier
Singri, P., West, D. P. & Gordon, K. B., May 1 2002, In: Archives of Dermatology. 138, 5, p. 657-663 7 p.
Research output: Contribution to journal › Review article › peer-review
101 Scopus citations
Safety of the new macrolide immunomodulators
Robinson, N., Singri, P. & Gordon, K. B., 2001, In: Seminars in cutaneous medicine and surgery. 20, 4, p. 242-249 8 p.
Research output: Contribution to journal › Article › peer-review
17 Scopus citations
'Two feet-one hand' syndrome: A recurring infection with a peculiar connection
Singri, P. & Brodell, R. T., Jan 1 1999, In: Postgraduate Medicine. 106, 2, p. 83-84 2 p.
Research output: Contribution to journal › Article › peer-review

2 Scopus citations
Medical and financial aspects of same-day bilateral total knee arthroplasties
Kovacik, M. W., Singri, P., Khanna, S. & Gradisar, I. A., Dec 1 1997, In: Biomedical Sciences Instrumentation. 33, p. 429-434 6 p.
Research output: Contribution to journal › Article › peer-review
22 Scopus citations